1. Academic Validation
  2. Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia

Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia

  • Exp Cell Res. 2024 May 15;438(2):114061. doi: 10.1016/j.yexcr.2024.114061.
Xing Ye 1 Zi-Jie Lin 2 Guang-Hui Hong 2 Zhi-Min Wang 2 Run-Ting Dou 2 Jun-Yi Lin 2 Jian-Hui Xie 2 Yi-Wen Shen 3
Affiliations

Affiliations

  • 1 Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China; Department of Forensic Medicine, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, 341000, China.
  • 2 Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
  • 3 Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. Electronic address: shenyiwen@fudan.edu.cn.
Abstract

Acute myocardial infarction (AMI) is a prevalent Cardiovascular Disease with high morbidity and mortality rates worldwide. Pyroptosis is an inflammatory form of programmed cell death that has been linked to various pathological conditions. However, its exact contribution to the onset and progression of heart injury in AMI has not yet fully elucidated. Herein, we established mouse AMI model by ligating the left anterior descending artery and performed transcriptome analysis during the early phase of AMI. Mouse HL-1 and human AC-16 cardiomyocytes were subjected to hypoxia to simulate ischemic injury in vitro. Our results revealed a significant activation of the inflammatory response at 3 h post-ligation, as confirmed by RNA Sequencing. We identified the occurrence of NLRP3 inflammasome-mediated Pyroptosis in the cardiac tissues of human cases with AMI, as well as in mouse models of AMI and hypoxia-induced cardiomyocytes, using immunohistochemistry staining and Western blotting assays. Concurrently, pharmacological inhibition of NLRP3 inflammasome-mediated Pyroptosis with MCC950 and VX-765 effectively decreased hypoxia-induced cardiomyocytes injury, while mitigating myocardial oxidative stress, Apoptosis and inflammation caused by hypoxia. Moreover, the circulating levels of gasdermin D (GSDMD), the Pyroptosis executor, were remarkably elevated in the plasma of mice with early AMI and in the supernatant of hypoxia-exposed cardiomyocytes in a time-dependent manner using ELISA and Western blotting. Furthermore, the change in circulating GSDMD positively correlated with Creatine Kinase-MB (CK-MB) in the plasma of early-stage AMI mouse. In summary, these findings indicated a critical role for NLRP3 inflammasome-mediated Pyroptosis in the progression of AMI, the administration of MCC950 and VX-765 may be attractive candidate therapeutic approaches for cardiac injury caused by acute hypoxia or even AMI. Additionally, the circulating GSDMD exhibits potential as a newly diagnostic biomarker for AMI.

Keywords

Acute myocardial infarction; Hypoxia; NLRP3 inflammasome; Pyroptosis.

Figures
Products